LPL Financial Portfolio holdings
LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE Value ETF
EFV
|
+$337M |
| 2 |
iShares Core Universal USD Bond ETF
IUSB
|
+$308M |
| 3 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$228M |
| 4 |
Microsoft
MSFT
|
+$197M |
| 5 |
Apple
AAPL
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$89.7M |
| 2 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
+$79.9M |
| 3 |
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
|
+$77.7M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$48.7M |
| 5 |
iShares Russell Mid-Cap ETF
IWR
|
+$43.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.9% |
| 2 | Financials | 3.36% |
| 3 | Healthcare | 2.79% |
| 4 | Consumer Discretionary | 2.72% |
| 5 | Industrials | 2.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4901
Oramed Pharmaceuticals
ORMP
$167M
| $94.4K | ﹤0.01% |
38,681
-1,790
| -4% | -$4.36K |
|
4902
CALL
Iovance Biotherapeutics
IOVA
$1.82B
| $93.9K | ﹤0.01% |
+10,000
| New | +$94.7K |
|
4903
Emergent Biosolutions
EBS
$373M
| $93.9K | ﹤0.01% |
+11,245
| New | +$102K |
|
4904
Zevra Therapeutics
ZVRA
$562M
| $93.8K | ﹤0.01% |
13,515
-2,809
| -17% | -$19.1K |
|
|
VERV
4905
DELISTED
Verve Therapeutics
VERV
| $93.6K | ﹤0.01% |
19,347
+6,308
| +48% | +$36.6K |
|
|
IAE
4906
Voya Asia Pacific High Dividend Equity Income Fund
IAE
$91.8M
| $93.3K | ﹤0.01% |
13,614
+94
| +0.7% | +$601 |
|
|
AILE
4907
DELISTED
iLearningEngines, Inc. Common Stock
AILE
| $92.6K | ﹤0.01% |
+55,440
| New | +$283K |
|
4908
Bumble
BMBL
$372M
| $92.4K | ﹤0.01% |
14,483
-2,316
| -14% | -$17.4K |
|
4909
Compass Therapeutics
CMPX
$344M
| $92K | ﹤0.01% |
50,000
| – | – |
|
4910
Ring Energy
REI
$315M
| $91.3K | ﹤0.01% |
57,038
-1,500
| -3% | -$2.68K |
|
|
RGLS
4911
DELISTED
Regulus Therapeutics
RGLS
| $91K | ﹤0.01% |
57,980
+11,000
| +23% | +$18.2K |
|
4912
Cohen & Co
COHN
$33.3M
| $90.3K | ﹤0.01% |
10,762
| – | – |
|
|
NXDT
4913
NexPoint Diversified Real Estate Trust
NXDT
$234M
| $89.1K | ﹤0.01% |
14,251
+304
| +2% | +$1.8K |
|
|
ELBM
4914
Electra Battery Materials
ELBM
$54.9M
| $89K | ﹤0.01% |
38,908
-8,312
| -18% | -$16.1K |
|
4915
SelectQuote
SLQT
$132M
| $87.1K | ﹤0.01% |
40,150
-100
| -0.2% | -$328 |
|
4916
AirSculpt Technologies
AIRS
$339M
| $86.7K | ﹤0.01% |
17,097
| – | – |
|
4917
NET Power
NPWR
$126M
| $85.5K | ﹤0.01% |
12,204
-2,230
| -15% | -$18.7K |
|
4918
Nektar Therapeutics
NKTR
$2.39B
| $85.5K | ﹤0.01% |
4,383
+1,097
| +33% | +$20.9K |
|
4919
Acurx Pharmaceuticals
ACXP
$6.19M
| $85.1K | ﹤0.01% |
2,239
-448
| -17% | -$19K |
|
4920
Cognyte Software
CGNT
$659M
| $84.5K | ﹤0.01% |
12,448
-2,575
| -17% | -$18.8K |
|
4921
Clarus
CLAR
$123M
| $84.5K | ﹤0.01% |
18,769
-65,497
| -78% | -$330K |
|
|
ADAP
4922
DELISTED
Adaptimmune Therapeutics
ADAP
| $84.4K | ﹤0.01% |
88,856
-110,000
| -55% | -$125K |
|
|
MOMO
4923
Hello Group
MOMO
$885M
| $84.4K | ﹤0.01% |
11,091
+239
| +2% | +$1.58K |
|
|
SRTA
4924
Strata Critical Medical Inc
SRTA
$434M
| $84.4K | ﹤0.01% |
28,696
-1,087
| -4% | -$3.46K |
|
4925
Protara Therapeutics
TARA
$220M
| $84.2K | ﹤0.01% |
46,000
+2,000
| +5% | +$4.11K |
|
Similar funds
LPL Financial's Q3 2024 Portfolio in Review
As of Q3 2024, LPL Financial held 5,335 positions worth $224B, up 12% from $201B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
LPL Financial deployed $12.1B of net new capital in Q3 2024, opening 324 new positions and adding to 3,037 existing holdings. Its largest new stake was AB International Low Volatility Equity ETF: 419,588 shares worth $15.4M.
By sector, the portfolio is most concentrated in Technology at 7.9% of assets, down from 8.1% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Energy Select Sector SPDR ETF, an estimated $89.7M trimmed.
- LPL Financial's largest Q3 2024 buy was AB International Low Volatility Equity ETF: 419,588 shares worth $15.4M.
- LPL Financial added most to iShares MSCI EAFE Value ETF in Q3 2024, an estimated $337M increase.
- LPL Financial's biggest Q3 2024 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $89.7M.
- LPL Financial fully exited Encore Wire Corp in Q3 2024, selling an estimated $15.2M.
- LPL Financial's ten largest holdings make up 16% of its $224B portfolio in Q3 2024.
- LPL Financial opened 324 new positions and closed 179 in Q3 2024.
- LPL Financial's portfolio value rose 12% quarter-over-quarter to $224B.
Based on LPL Financial's 13F filing for Q3 2024, filed 8 Nov 2024.